FREE PREMIUM SUBSCRIPTION FOR 14 DAYS!

Assembly Biosciences Stock Forecast NASDAQ:ASMB

Price Target and Analyst Ratings

Most Recent Rating

On May 17, 2021 "SVB Leerink" gave "Market Perform" rating for ASMB. The price target was changed from $8.00 to $7.00.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-05-17 Market Perform Target Lowered by SVB Leerink $3.98 $8.00 → $7.00
2021-05-11 Buy Reiterated by Mizuho $3.97 $13.00
2021-05-10 Market Perform Target Lowered by SVB Leerink $3.90 $8.00 → $7.00
2021-03-29 Outperform - Market Perform Reiterated by SVB Leerink $4.33 $9.00 → $8.00
2021-03-23 Outperform - Market Perform Downgraded by SVB Leerink $4.45 $9.00 → $8.00
2021-03-02 Target Lowered by Truist $4.99 $45.00 → $15.00
2021-02-28 Buy Reiterated by Robert W. Baird $5.08
2021-02-25 Buy Reiterated by Mizuho $5.53 $13.00
2020-12-04 Buy Target Lowered by Mizuho $6.21 $30.00 → $13.00
2020-11-06 Buy - Hold Downgraded by Jefferies Financial Group $4.87 $30.00 → $10.00
2020-10-19 Buy Initiated by Truist $15.55 $55.00
2020-07-08 Outperform Target Raised by SVB Leerink $24.21 $36.00 → $38.00
2020-06-25 Buy Reiterated by William Blair $23.81
2020-05-12 Buy Reiterated by William Blair $20.35
2020-05-08 Buy Reiterated by Mizuho $19.89 $30.00

ASMB Stock Trend

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -13.33% during the next 3 months and, with a 90% probability hold a price between $2.85 and $3.56 at the end of this 3-month period.

Data

Date Bottom Mid Top
2021-08-03 $3.28 $3.69 $4.09
2021-08-04 $3.27 $3.68 $4.08
2021-08-05 $3.26 $3.67 $4.07
2021-08-06 $3.25 $3.66 $4.06
2021-08-09 $3.24 $3.65 $4.05
2021-08-10 $3.23 $3.63 $4.04
2021-08-11 $3.22 $3.62 $4.03
2021-08-12 $3.21 $3.61 $4.02
2021-08-13 $3.20 $3.60 $4.01
2021-08-16 $3.19 $3.59 $4.00
2021-08-17 $3.18 $3.58 $3.99
2021-08-18 $3.17 $3.57 $3.98
2021-08-19 $3.16 $3.56 $3.97
2021-08-20 $3.15 $3.55 $3.96
2021-08-23 $3.14 $3.54 $3.95
2021-08-24 $3.13 $3.53 $3.94
2021-08-25 $3.12 $3.52 $3.93
2021-08-26 $3.10 $3.51 $3.92
2021-08-27 $3.09 $3.50 $3.91
2021-08-30 $3.08 $3.49 $3.90
2021-08-31 $3.07 $3.48 $3.89
2021-09-01 $3.06 $3.47 $3.88
2021-09-02 $3.05 $3.46 $3.87
2021-09-03 $3.04 $3.45 $3.86
2021-09-07 $3.03 $3.44 $3.85
2021-09-08 $3.02 $3.43 $3.84
2021-09-09 $3.01 $3.42 $3.83
2021-09-10 $3.00 $3.41 $3.82
2021-09-13 $2.99 $3.40 $3.81
2021-09-14 $2.98 $3.39 $3.80

About Assembly Biosciences

Assembly Biosciences Assembly Biosciences, Inc., a biotechnology company, develops oral therapeutics for the treatment of hepatitis B virus (HBV) infection and to restore health to a dysbiotic microbiome in the United States. It is involved in developing core protein allosteric modulators that modulate the HBV core protein, a polyfunctional viral protein at various points in the viral lifecycle. The company also develops microbiome program, a platform that includes t... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT